EMA - Advice to sponsors on managing the impact of the war in Ukraine on clinical trials

6th April 2022

Advice to sponsors on managing the impact of the war in Ukraine on clinical trials

In view of the disruptions caused by the Russian invasion of Ukraine, the European Commission (EC), the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) are issuing initial advice for sponsors on how to manage the conduct of clinical trials in this situation.

Read More

 

Back to News Archive